Salignostics is founded in 2016, operates from its headquarter in Jerusalem Bio-Park Jerusalem, Jerusalem 91120, IL. The company operates in the Hospitals & Healthcare, Nursing Homes and Residential Care Facilities sector.
Salignostics specializes in Saliva based diagnostics, Rapid diagnostic test development, Lateral flow immunoassay technology, Overcoming saliva related chemical and biological obstacles, and offers services including Saliva based rapid diagnostics tests (RDT), Lateral flow immunoassay platform.
Salignostics. During the past 6 months, 1 employees departed.
Total Rounds
US$ 8M
Last Round
US$ 8M
Rounds
1